Johnson and Johnson Newswire (Page 5)

Comprehensive Real-Time News Feed for Johnson and Johnson. (Page 5)

Results 81 - 100 of 12,423 in Johnson and Johnson

  1. Risperdal Lawyers at Bernstein Liebhard LLP Look Ahead to June Meeting...Read the original story w/Photo

    Thursday May 21 | PRWeb

    The Firm is representing Risperdal lawsuit plaintiffs who allegedly experienced gynecomastia, or male breast growth, due to their use of the antipsychotic medication. Our Firm is representing Risperdal plaintiffs who allegedly experienced excessive male breast development as a result of treatment with this medication.


  2. J&J to submit at least 10 new drugs for approval by 2019Read the original story

    Wednesday May 20 | Reuters

    U.S. healthcare conglomerate Johnson & Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United States and Europe this year based on mid-stage clinical data.


  3. Johnson & Johnson expects lucrative return on drug pipelineRead the original story w/Photo

    Wednesday May 20 | SFGate

    Johnson & Johnson says its pharmaceutical business expects to seek regulatory approval by 2019 for more than 10 new products, each with the potential to top $1 billion in annual sales. The health care products maker says its Janssen Pharmaceutical Companies business also will pursue approvals of more than 40 additional uses for existing or new products.


  4. Achillion-Janssen Deal Boosts Achillion's Progress In Competing In Hepatitis-CRead the original story w/Photo

    Wednesday May 20 | Seeking Alpha

    ... it has entered into a worldwide partnership with Janssen Pharmaceuticals, the pharmaceutical division of Johnson and Johnson (NYSE: JNJ ), allowing them to work together on developing shorter treatments in the lucrative Hepatitis-C market. Back in ...


  5. Achillion, Johnson & Johnson Hammer Out $1 Billion+ Hep C R&D Pact to ...Read the original story

    Tuesday May 19 | BioSpace

    ... from JNJ in return for 18.4 million unregistered shares at $12.25 per share. The deal is a sign that Johnson and Johnson is looking to get ahead of the curve as "cure" treatments have begun appearing in the hepatitis C space, including the drugs ...


  6. Like Big Dividends? 6 Steady Payers You Can Rely OnRead the original story w/Photo

    Tuesday May 19 | Investor's Business Daily

    Here are six of the most reliable dividend payers whose yields also beat the market. IBD's Dividend Stability Factor shows how stable a company's dividend history is over a five-year period.


  7. Chicopee golf director let go amid financial woesRead the original story w/Photo

    Tuesday May 19 | The Times

    Deteriorating conditions and dwindling revenues have prompted officials at the Chicopee Woods Golf Course to lay off the director of golf, take ownership of the pro shop and consider a shakeup of members on an oversight committee in an effort to get the ball back on the green. It also has stirred concerns about whether Hall County taxpayers might soon be on the hook for nearly $3 million in bond debt owed by the course.


  8. Takata Doubles Defective Airbag Recall to 34M VehiclesRead the original story w/Photo

    Tuesday May 19 | Fox News

    Japanese auto supplier Takata has acknowledged that airbag inflators used in nearly 34 million U.S. vehicles are defective, setting up a massive recall that covers most major automakers. The decision will double the number of recalled vehicles to a current estimate of 33.8 million, the National Highway Traffic Safety Administration said Tuesday.


  9. Johnson & Johnson Expands IP Policy to Create Broad Access in Caribbean for Children Living with HIVRead the original story

    Tuesday May 19 | Bajan Reporter

    Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have furthered their commitment to improve the health of children living with HIV through an expanded policy aimed at enhancing access to its HIV medicine darunavir . This policy enables the development of and access to new pediatric products of darunavir in 128 low- and middle-income countries[ i ], home to 99.8% of children and adolescents living with HIV worldwide[ ii ] today.


  10. Janssen Supply Chain expands collaboration with Rutgers with $6 million in fundingRead the original story w/Photo

    Sunday May 17 | EurekAlert!

    Arrangement to implement continuous manufacturing initiative; broadening a strategic collaboration with the Engineering Research Center for Structured Organic Particulate Systems to help create the future of advanced manufacturing Janssen Supply Chain has furthered its strategic partnership with the Rutgers University School of Engineering by providing over $6 million to expand ongoing research efforts supporting the company's introduction of continuous manufacturing techniques for pharmaceuticals.


  11. New FDA Warning Impacts Diabetes Drugs Made by AstraZeneca PLC, Johnson & Johnson and Eli LillyRead the original story

    Sunday May 17 | BioSpace

    May 18, 2015 By Alex Keown , Breaking News Staff WASHINGTON - The U.S. Food and Drug Administration is investigating diabetes drugs used to treat Type 2 diabetes made by Johnson & Johnson , AstraZeneca PLC and Eli Lilly and Company after 20 cases of ketoacidosis which required hospitalization were reported. Federal regulators fired off a warning Friday that sodium-glucose cotransporter-2 inhibitors used to treat type 2 diabetes may lead to diabetic ketoacidosis requiring hospitalization.


  12. Court upholds $50 million award for girl whose life was destroyed by...Read the original story w/Photo

    Sunday May 17 |

    The Massachusetts Supreme Judicial Court upheld a lower court's judgment that pharmaceutical giant Johnson & Johnson should be required to pay $50 million to a girl who suffered a rare but devastating side effect from Children's Motrin when she was seven years old. The judgment took more than a decade to be reached.


  13. US court halts contentious law on contact lens price-fixingRead the original story w/Photo

    Sunday May 17 | KIII

    A law banning price-fixing for contact lenses that took effect this week in Utah is a setback for the nation's largest... . A contact lens is shown in front of a 1-800-Contacts shipping box Wednesday, May 13, 2015, in Salt Lake City. 2 comments

  14. U.S. IPO Weekly Recap: With 6 IPOs, The Year's Largest Company Goes PublicRead the original story w/Photo

    Sunday May 17 | Seeking Alpha

    Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return.


  15. Ken Fisher Adds to His Johnson and Johnson PositionRead the original story w/Photo

    Saturday May 16 |

    ... the past five years. The company also has a very good record in terms of returning cash to shareholders. Johnson and Johnson has returned about 70% of its free cash flow over the past decade, which amounts to about $90 billion. Going forward, the ...


  16. Jeff Reim Jeff ReimRead the original story

    Saturday May 16 | Voices

    Clear and smooth, natural baritone voice for any copy. Extremely versatile, with a wide variety of character voices.


  17. Apple Inc.( AAPL), The Coca-Cola Co (KO): Billionaire Ray Dalio's Top PicksRead the original story w/Photo

    Friday May 15 | Insider Monkey

    Billionaire Ray Dalio founded Bridgewater Associates , one of the world's largest funds, in 1973. Dalio earned a Bachelor of Arts/Science from Long Island University and an MBA from Harvard Business School.


  18. Business in brief: Honda issues massive air bag recallRead the original story w/Photo

    Friday May 15 | Erie Times News

    A massive new recall from Honda of vehicles with Takata air bags Thursday has brought the total recalls for the potentially deadly devices to more than 33 million. Honda Motor Co.


  19. Sientra: Sales Team And Product Expansion To Drive Share Price In 2015Read the original story w/Photo

    Friday May 15 | Seeking Alpha

    SIEN continues to grow its footprint in the lucrative and closed off breast implant niche of the med aesthetics space. SIEN has plans for both sales team and product portfolio expansion later in the year which should pull share price forward in run up.


  20. Johnson & Johnson: The 'Tragedy' Of Paying 17 Times EarningsRead the original story w/Photo

    Friday May 15 | Seeking Alpha

    This article demonstrates that whether or not a lower valuation would be a "tragedy" depends on a couple of factors. If you were looking for a quintessential "blue-chip" stock example, you'd be hard-pressed to overlook a company like Johnson & Johnson .